2Rifai N,Ridker PM. High- sensitivity C- reactive protein :a novel and promising marker of coronary heart disease[J]. Clin Chem,2001,47(3):403 - 411.
3Koukkunen H, Penttila Kemppainen A. C- reactive protein, fibrinogen,interleukin- 6 and tumor necrosis facteralpha in the prognostic classification of unstable angina pectoris[J]. Ann Med,2001,33(1) :37- 47.
2Reinhold M, Deppisch W, Hermann G. Complement components as uremic toxins and their potential role as mediators of microinflammation. Kidney Int, 2001,59:271-279.
3Ikeda U, Ileda M, Seiono Y, et al. Interleukin -6 gene transcripts are expressed in atherrosclerotic lesion of the genetically hyperlipidemic rabbits. Atherosclerosis, 1992,92: 213-218.
4Antonio S, Elena M. Cardiac effects of chronic inflammation in dialysis patients. Nephrol Dial Transplant. 2002,17: 10-15.
5Kim K J, Yang WS, Kim SB, et al. Malnutrition, cardiac disease,and mortality: an integrated point of view. Am J Kindey Dis,1998, 32: 834-841.
6Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis,1998; 32: s112-s119.
7Ridker PM, Buring JE, Shin J. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparentl healthy women. Circulation, 1998,98:731-733.
8George A. The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol,2001,12: 1549-1557.
9Vigushin DM, Pepys MB. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest, 1993,91: 1351-1357.
10Ridker PM.High-sensitivity C-reactive protein:potential adjunct for global risk assessment in the primary prevention of cardiovascular disease.Circulation,2001,103(13):1813-1818.
